This study aims to understand how advanced artificial pancreas closed-loop technology helps children and teenagers (ages 6 to 17) with type 1 diabetes, especially those from lower-income backgrounds. These technologies use a continuous glucose monitor (CGM), which tracks blood sugar without finger-prick calibrations, to automatically deliver insulin. We want to see if using these devices improves blood sugar control, measured by how much time a person's blood sugar stays in a healthy range. You might be able to join if you have had type 1 diabetes for at least a year, are currently on insulin therapy, and have an HbA1C (a measure of average blood sugar over 2-3 months) of 8.0% or higher at least twice in the last year. The study is currently unclear about its recruitment status and plans to enroll 50 participants.

Study design

This is an observational study, meaning researchers will collect data before and after participants start using an FDA-approved closed-loop system. About 50 children and adolescents will be included.

What's involved

Participants will transition to a closed-loop system with assistance from an insurance navigator. They will receive diabetes care as usual, with periodic device downloads.

Compensation

Not stated in the trial record.

Follow-up

Blood sugar control will be measured at 3 months after starting the closed-loop system.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.